| 2025-11-04 |
详情>>
股本变动：
变动后总股本3959.97万股
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.28美元,归母净利润-8997万美元,同比去年增长7.10%
|
| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘前发布财报
|
| 2025-08-18 |
详情>>
内部人交易：
Fisher Patrick股份减少1996.00股
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益-1.71美元,归母净利润-6717.5万美元,同比去年增长3.29%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益-1.35美元,归母净利润-5309.4万美元,同比去年增长-47.4%
|
| 2025-04-30 |
股东大会：
将于2025-06-18召开股东大会
会议内容 ▼▲
- 1.Election of Directors. Shareholders will be asked to elect the following ten persons to the Board: Alan L. Bazaar, Wayne Burris, Massimo Calafiore, Vickie L. Capps, Michael M. Finegan, Jason M. Hannon, John B. Henneman, III, Charles R. Kummeth, Shweta Singh Maniar, and Michael E. Paolucci. The Board unanimously recommends that shareholders vote “FOR” each of the foregoing director nominees.
2.Advisory and Non-Binding Resolution to Approve Executive Compensation. Shareholders will be asked to approve an advisory and non-binding resolution on the compensation of the Company’s named executive officers, as described in the “Compensation Discussion and Analysis” and the related compensation tables beginning on page 28 of this proxy statement. The Board unanimously recommends that shareholders vote “FOR” this proposal.
3.Ratification of the Appointment of EY as Independent Registered Public Accounting Firm for 2025. Shareholders will be asked to approve a resolution to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2025. The Board unanimously recommends that shareholders vote “FOR” this proposal.
4.Miscellaneous. Shareholders will be asked to transact such other business as may come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-02-25 |
详情>>
业绩披露：
2024年年报每股收益-3.3美元,归母净利润-1.26亿美元,同比去年增长16.78%
|
| 2025-02-25 |
详情>>
业绩披露：
2022年年报每股收益-0.98美元,归母净利润-1974.9万美元,同比去年增长48.54%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.55美元,归母净利润-9685.1万美元,同比去年增长25.05%
|
| 2024-08-06 |
详情>>
业绩披露：
2023年中报每股收益-2.77美元,归母净利润-1亿美元,同比去年增长-4992.03%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-1.84美元,归母净利润-6946.3万美元,同比去年增长30.79%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.95美元,归母净利润-3602万美元,同比去年增长40.89%
|
| 2024-04-29 |
股东大会：
将于2024-06-18召开股东大会
会议内容 ▼▲
- 1.Election of Directors. Shareholders will be asked to elect the following nine persons to the Board: Alan L. Bazaar, Wayne Burris, Massimo Calafiore, Michael M. Finegan, Jason M. Hannon, John B. Henneman, III, Charles R. Kummeth, Shweta Singh Maniar, and Michael E. Paolucci. The Board unanimously recommends that shareholders vote “FOR” each of the foregoing director nominees.
2.Advisory and Non-Binding Resolution to Approve Executive Compensation. Shareholders will be asked to approve an advisory and non-binding resolution on the compensation of the Company’s named executive officers, as described in the “Compensation Discussion and Analysis” and the related compensation tables beginning on page 27 of this proxy statement. The Board unanimously recommends that shareholders vote “FOR” this proposal.
3.Ratification of the Appointment of EY as Independent Registered Public Accounting Firm for 2024. Shareholders will be asked to approve a resolution to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2024. The Board unanimously recommends that shareholders vote “FOR” this proposal.
4.Approval of Amendment No. 5 to the Amended and Restated 2012 LTIP. Shareholders will be asked to approve Amendment No. 5 to the Company’s Amended and Restated 2012 Long-Term Incentive Plan to increase the number of shares available for issuance thereunder. The Board unanimously recommends that shareholders vote “FOR” this proposal.
5.Approval of Amendment No. 4 to the Second Amended and Restated Stock Purchase Plan. Shareholders will be asked to approve Amendment No. 4 to the Company’s Second Amended and Restated Stock Purchase Plan to increase the number of shares available for issuance thereunder. The Board unanimously recommends that shareholders vote “FOR” this proposal.
6.Miscellaneous. Shareholders will be asked to transact such other business as may come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-03-05 |
详情>>
业绩披露：
2023年年报每股收益-4.12美元,归母净利润-1.51亿美元,同比去年增长-666.6%
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-3.53美元,归母净利润-1.29亿美元,同比去年增长-918.53%
|
| 2023-04-27 |
股东大会：
将于2023-06-19召开股东大会
会议内容 ▼▲
- 1.Election of Directors. Shareholders will be asked to elect the following nine persons to the Board: Wayne Burris, Catherine M. Burzik, Stuart M. Essig, Ph.D., Jason M. Hannon, John B. Henneman, III, James F. Hinrichs, Shweta Singh Maniar, Michael E. Paolucci, and Keith C. Valentine. The Board unanimously recommends that shareholders vote “FOR” each of the foregoing director nominees.
2.Advisory and Non-Binding Resolution to Approve Executive Compensation. Shareholders will be asked to approve an advisory and non-binding resolution on the compensation of the Company’s named executive officers, as described in the “Compensation Discussion and Analysis” and the related compensation tables beginning on page 25 of this proxy statement. The Board unanimously recommends that shareholders vote “FOR” this proposal.
3.Ratification of the Appointment of EY as Independent Registered Public Accounting Firm for 2023. Shareholders will be asked to approve a resolution to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2023. The Board unanimously recommends that shareholders vote “FOR” this proposal.
4.Approval of an Amended and Restated Certificate of Incorporation to Increase the Authorized Number of Shares of Common Stock From 50 Million to 100 Million. Shareholders will be asked to approve an Amended and Restated Certificate of Incorporation, including a proposal to increase the number of authorized shares of common stock from 50 million to 100 million. The Board unanimously recommends that shareholders vote "FOR" this proposal.
5.Approval of an Amended and Restated Certificate of Incorporation to Provide for Exculpation of Officers as Permitted by Recent Amendments to Delaware Law. Shareholders will be asked to approve an Amended and Restated Certificate of Incorporation, including a proposal to provide for exculpation of officers as permitted by recent amendments to Delaware law. The Board unanimously recommends that shareholders vote "FOR" this proposal.
6.Approval of an Amendment and Restatement of the Certificate of Incorporation to Add Forum Selection Provisions. Shareholders will be asked to approve an Amended and Restated Certificate of Incorporation, including a proposal regarding the addition of forum selection provisions. The Board unanimously recommends that shareholders vote "FOR" this proposal.
7.Approval of Amendment No. 4 to the Amended and Restated 2012 LTIP. Shareholders will be asked to approve Amendment No. 4 to the Company’s Amended and Restated 2012 Long-Term Incentive Plan. The Board unanimously recommends that shareholders vote “FOR” this proposal.
8.Approval of Amendment No. 3 to the Second Amended and Restated Stock Purchase Plan. Shareholders will be asked to approve Amendment No. 3 to the Company’s Second Amended and Restated Stock Purchase Plan to increase the number of shares available for issuance thereunder. The Board unanimously recommends that shareholders vote “FOR” this proposal.
9.Advisory and Non-Binding Vote on the Preferred Frequency of Holding an Advisory and Non-Binding Resolution to Approve Executive Compensation. Shareholders will be asked to indicate, on an advisory basis, their preferred frequency of holding an advisory vote on the compensation of our named executive officers. The frequency options are to hold the advisory vote every year, every two years or every three years. The Board unanimously recommends that shareholders vote to hold the advisory vote on the compensation of our named executive officers every year.
10.Miscellaneous. Shareholders will be asked to transact such other business as may come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-04-27 |
股东大会：
将于2022-06-06召开股东大会
会议内容 ▼▲
- 1.Shareholders will be asked to elect the following nine persons to the Board: Wayne Burris, Catherine M. Burzik, Jason M. Hannon, James F. Hinrichs, Lilly Marks, Michael E. Paolucci, Jon Serbousek, John E. Sicard, and Thomas A. West. The Board unanimously recommends that shareholders vote “FOR” each of the foregoing director nominees.
2.Shareholders will be asked to approve an advisory and non-binding resolution on the compensation of the Company’s named executive officers, as described in the “Compensation Discussion and Analysis” and the related compensation tables beginning on page 22 of this proxy statement. The Board unanimously recommends that shareholders vote “FOR” the proposal to approve the advisory and non-binding resolution on executive compensation.
3.Shareholders will be asked to approve Amendment No. 3 to the Company’s Amended and Restated 2012 Long-Term Incentive Plan (the “LTIP Amendment”). The Board unanimously recommends that shareholders vote “FOR” the proposal to approve the LTIP Amendment.
4.Shareholders will be asked to approve a resolution to ratify the selection of Ernst & Young LLP (“EY”) as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2022. The Board unanimously recommends that shareholders vote “FOR” the proposal to ratify the selection of EY as the independent registered public accounting firm.
5.Shareholders will be asked to transact such other business as may come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-06-21召开股东大会
会议内容 ▼▲
- 1.Election of Directors.Shareholders will be asked to elect the following eight persons to the Board: Catherine M. Burzik, Jason M. Hannon, James F. Hinrichs, Alexis V. Lukianov, Lilly Marks, Michael E. Paolucci, Jon Serbousek, and John E. Sicard. The Board unanimously recommends that shareholders vote “FOR” each of the foregoing director nominees.
2.Advisory and Non-Binding Resolution to Approve Executive Compensation.Shareholders will be asked to approve an advisory and non-binding resolution on the compensation of the Company’s named executive officers, as described in the “Compensation Discussion and Analysis” and the related compensation tables beginning on page 20 of this proxy statement. The Board values shareholders’ opinions, and the Compensation Committee of the Board will take into account the outcome of the advisory vote when considering future executive compensation decisions. The Board unanimously recommends that shareholders vote “FOR” the proposal to approve the advisory and non-binding resolution on executive compensation.
3.Approval of Amendment No. 2 to the Amended and Restated 2012 LTIP.Shareholders will be asked to approve Amendment No. 2 to the Company’s Amended and Restated 2012 Long-Term Incentive Plan (the “LTIP Amendment”). The Board unanimously recommends that shareholders vote “FOR” the proposal to approve the LTIP Amendment.
4.Approval of Amendment No. 2 to the Second Amended and Restated Stock Purchase Plan.Shareholders will be asked to approve Amendment No. 2 to the Company’s Second Amended and Restated Stock Purchase Plan (the “SPP”) to increase the number of shares subject to awards under the SPP (the “SPP Amendment”). The Board unanimously recommends that shareholders vote “FOR” the proposal to approve the SPP Amendment.
5.Ratification of the Selection of EY as Independent Registered Public Accounting Firm for 2021.Shareholders will be asked to approve a resolution to ratify the selection of Ernst & Young LLP (“EY”) as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2021. The Board unanimously recommends that shareholders vote “FOR” the proposal to ratify the selection of EY as the independent registered public accounting firm.
6.Miscellaneous.Shareholders will be asked to transact such other business as may come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-04-29 |
股东大会：
将于2020-06-08召开股东大会
会议内容 ▼▲
- 1.Election of Directors. Shareholders will be asked to elect the following persons to the Board: Jason M. Hannon, James F. Hinrichs, Alexis V. Lukianov, Lilly Marks, Ronald A. Matricaria, Michael E. Paolucci, Maria Sainz, Jon Serbousek, and John Sicard. The Board unanimously recommends that shareholders vote “FOR” each of the foregoing director nominees.
2.Advisory and Non-Binding Resolution to Approve Executive Compensation. Shareholders will be asked to approve an advisory and non-binding resolution on the compensation of the Company’s named executive officers, as described in the “Compensation Discussion and Analysis” and the related compensation tables beginning on page 16 of this proxy statement. The Board values shareholders’ opinions, and the Compensation Committee of the Board will take into account the outcome of the advisory vote when considering future executive compensation decisions. The Board unanimously recommends that shareholders vote “FOR” the proposal to approve the advisory and non-binding resolution on executive compensation.
3.Approval of Amendment No. 1 to the Amended and Restated 2012 LTIP. Shareholders will be asked to approve Amendment No. 1 to the Company’s Amended and Restated 2012 Long-Term Incentive Plan (the “LTIP Amendment”). The Board unanimously recommends that shareholders vote “FOR” the proposal to approve the LTIP Amendment.
4.Ratification of the Selection of EY as Independent Registered Public Accounting Firm for 2020. Shareholders will be asked to approve a resolution to ratify the selection of Ernst & Young LLP (“EY”) as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2020. The Board unanimously recommends that shareholders vote “FOR” the proposal to ratify the selection of EY as the independent registered public accounting firm.
5.Miscellaneous. Shareholders will be asked to transact such other business as may come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-04-29 |
股东大会：
将于2019-06-10召开股东大会
会议内容 ▼▲
- 1.Election of Directors. Shareholders will be asked to elect the following persons to the Board: James F. Hinrichs, Alexis V. Lukianov, Lilly Marks, Bradley R. Mason, Ronald A. Matricaria, Michael E. Paolucci, Maria Sainz and John Sicard. The Board unanimously recommends that shareholders vote “FOR” each of the foregoing director nominees.
2.Advisory and Non-Binding Resolution to Approve Executive Compensation. Shareholders will be asked to approve an advisory and non-binding resolution on the compensation of the Company’s named executive officers, as described in the “Compensation Discussion and Analysis” and the related compensation tables beginning on page 17 of this proxy statement. The Board values shareholders’ opinions, and the Compensation Committee of the Board will take into account the outcome of the advisory vote when considering future executive compensation decisions. The Board unanimously recommends that shareholders vote “FOR” the proposal to approve the advisory and non-binding resolution on executive compensation.
3.Ratification of the Selection of EY as Independent Registered Public Accounting Firm for 2019. Shareholders will be asked to approve a resolution to ratify the selection of Ernst & Young LLP (“EY”) as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2019. The Board unanimously recommends that shareholders vote “FOR” the proposal to ratify the selection of EY as the independent registered public accounting firm.
4.Miscellaneous. Shareholders will be asked to transact such other business as may come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2017-04-28 |
股东大会：
将于2017-06-13召开股东大会
会议内容 ▼▲
- 1.Election of Board of Directors. Shareholders will be asked to elect the following persons to the Board of Directors: Luke Faulstick, James F. Hinrichs, Alexis V. Lukianov, Lilly Marks, Bradley R. Mason, Ronald A. Matricaria, Michael E. Paolucci and Maria Sainz. The Board of Directors recommends that shareholders vote FOR each of the foregoing nominees for director.
2.Approval of Financial Statements for the Fiscal Year Ended December 31, 2016. Shareholders will be asked to approve the consolidated balance sheet and consolidated statement of operations at and for the fiscal year ended December 31, 2016. The Board of Directors recommends that shareholders vote FOR the proposal to approve the consolidated balance sheet and consolidated statement of operations at and for the fiscal year ended December 31, 2016.
3.Advisory and Non-Binding Resolution to Approve Executive Compensation. Shareholders will be asked to approve an advisory and non-binding resolution on the compensation of Named Executive Officers as described in the Compensation Discussion and Analysis beginning on page 13 and the compensation tables beginning on page 32. The Board values shareowners’ opinions, and the Compensation Committee will take into account the outcome of the advisory vote when considering future executive compensation decisions. The Board of Directors recommends that shareholders vote FOR the proposal to approve the advisory and non-binding resolution on executive compensation.
4.Advisory Vote on the Frequency of Future Advisory Votes To Approve Executive Compensation. Shareholders are being provided the opportunity to vote on how often they believe we should hold an advisory vote to approve executive compensation in the future. The frequency options are to hold the advisory vote to approve executive compensation each year, every two years or every three years. The Board believes that an annual advisory vote on executive compensation is the most appropriate policy for our shareholders and the Company at this time, and recommends that shareholders vote for the option “1 Year”.
5.Ratification of the Selection of Ernst & Young LLP. Shareholders will be asked to approve a resolution to ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2017. The Board of Directors recommends that shareholders vote FOR the proposal to ratify the selection of Ernst & Young LLP as the independent registered public accounting firm.
6.Miscellaneous. Shareholders will be asked to transact such other business as may come before the Annual General Meeting or any adjournment thereof.
|
| 2016-04-29 |
股东大会：
将于2016-06-14召开股东大会
会议内容 ▼▲
- 1.Election of Board of Directors. Shareholders will be asked to consider, and, if thought fit, approve a resolution to elect the following persons to the Board of Directors: Luke Faulstick, James F. Hinrichs, Guy J. Jordan, PhD, Lilly Marks, Anthony F. Martin, PhD, Bradley R. Mason, Ronald A. Matricaria, Michael E. Paolucci and Maria Sainz. The Board of Directors recommends that shareholders vote FOR each of the foregoing nominees for director.
2.Approval of Financial Statements for the Fiscal Year Ended December 31, 2015. Shareholders will be asked to consider, and, if thought fit, approve the consolidated balance sheet and consolidated statement of operations at and for the fiscal year ended December 31, 2015. The Board of Directors recommends that shareholders vote FOR the proposal to approve the consolidated balance sheet and consolidated statement of operations at and for the fiscal year ended December 31, 2015.
3.Advisory and Non-Binding Resolution on Executive Compensation. Shareholders will be asked to consider, and, if thought fit, approve an advisory and non-binding resolution on executive compensation. The Board of Directors recommends that shareholders vote FOR the proposal to approve
the advisory and non-binding resolution on executive compensation.
4.Ratification of the Selection of Ernst & Young LLP. Shareholders will be asked to consider, and, if thought fit, approve a resolution to ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December 31, 2016. The Board of Directors recommends that shareholders vote FOR the proposal to ratify the selection of Ernst & Young LLP as the independent registered public accounting firm.
5.Miscellaneous. Shareholders will be asked to transact such other business as may come before the Annual General Meeting or any adjournment thereof.
|